Spreadsheet: c56a3cd7-4898-43fb-a851-d4d545308e3f
Sheet: Websheets

 |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | FIRST QUARTER
 |  |  |  |  | % Change
 |  | 2012 |  | 2011 | Reported | Operational (1) | Currency
CONSUMER SEGMENT (2)
BABY CARE
US |  | 99 |  | 105 | -0.057 | -0.057 | 0
Intl |  | 441 |  | 456 | -0.033 | -0.004 | -0.029
WW |  | 540 |  | 561 | -0.037 | -0.014 | -0.023
ORAL CARE
US |  | 155 |  | 163 | -0.049 | -0.049 | 0
Intl |  | 232 |  | 228 | 0.018 | 0.047 | -0.029
WW |  | 387 |  | 391 | -0.01 | 0.007000000000000001 | -0.017
OTC/NUTRITIONALS
US |  | 381 |  | 397 | -0.04 | -0.04 | 0
Intl |  | 723 |  | 732 | -0.012 | 0.017 | -0.029
WW |  | 1104 |  | 1129 | -0.022 | -0.002999999999999999 | -0.019
SKIN CARE
US |  | 453 |  | 426 | 0.063 | 0.063 | 0
Intl |  | 454 |  | 473 | -0.04 | -0.017 | -0.023
WW |  | 907 |  | 899 | 0.009 | 0.021 | -0.012
WOMEN'S HEALTH
US |  | 93 |  | 125 | -0.256 | -0.256 | 0
Intl |  | 316 |  | 334 | -0.054 | -0.017 | -0.037
WW |  | 409 |  | 459 | -0.109 | -0.082 | -0.027
WOUND CARE/OTHER
US |  | 135 |  | 129 | 0.047 | 0.047 | 0
Intl |  | 113 |  | 114 | -0.009 | 0.017 | -0.026
WW |  | 248 |  | 243 | 0.021 | 0.033 | -0.012
TOTAL CONSUMER
US |  | 1316 |  | 1345 | -0.022 | -0.022 | 0
Intl |  | 2279 |  | 2337 | -0.025 | 0.003999999999999997 | -0.029
WW |  | 3595 |  | 3682 | -0.024 | -0.005999999999999998 | -0.018
See footnotes at end of schedule
 |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | FIRST QUARTER
 |  |  |  |  | % Change
 |  | 2012 |  | 2011 | Reported | Operational (1) | Currency
PHARMACEUTICAL SEGMENT  (2) (4)
IMMUNOLOGY
US |  | 1453 |  | 1436 | 0.012 | 0.012 | 0
Intl |  | 442 |  | 144 | * | * | -0.02219230769230769
WW |  | 1895 |  | 1580 | 0.199 | 0.2052082278481013 | -0.006208227848101266
REMICADE
US |  | 882 |  | 788 | 0.119 | 0.119 | 0
US Exports (3) |  | 378 |  | 490 | -0.229 | -0.229 | 0
Intl |  | 261 |  | 7 | * | * | -0.02222222222222222
WW |  | 1521 |  | 1285 | 0.184 | 0.184 | 0
SIMPONI
US |  | 64 |  | 53 | 0.208 | 0.208 | 0
Intl |  | 52 |  | 42 | 0.238 | 0.25 | -0.012
WW |  | 116 |  | 95 | 0.221 | 0.226 | -0.005
STELARA
US |  | 129 |  | 105 | 0.229 | 0.229 | 0
Intl |  | 92 |  | 61 | 0.508 | 0.5389130434782609 | -0.03091304347826087
WW |  | 221 |  | 166 | 0.331 | 0.348 | -0.017
OTHER IMMUNOLOGY
US |  | 0 |  | 0 | 0 | 0 | 0
Intl |  | 37 |  | 34 | 0.088 | 0.1074705882352941 | -0.01947058823529412
WW |  | 37 |  | 34 | 0.088 | 0.1074705882352941 | -0.01947058823529412
INFECTIOUS DISEASES
US |  | 242 |  | 624 | -0.6121794871794872 | -0.6121794871794872 | 0
Intl |  | 513 |  | 307 | 0.6710097719869706 | 0.7051169844626042 | -0.03410721247563353
WW |  | 755 |  | 931 | -0.1890440386680988 | -0.170250268528464 | -0.0187937701396348
INTELENCE
US |  | 43 |  | 38 | 0.132 | 0.132 | 0
Intl |  | 37 |  | 31 | 0.194 | 0.230027027027027 | -0.03602702702702703
WW |  | 80 |  | 69 | 0.159 | 0.1783188405797101 | -0.01931884057971014
LEVAQUIN/FLOXIN
US |  | 18 |  | 422 | -0.957 | -0.957 | 0
Intl |  | 11 |  | 12 | -0.083 | -0.048 | -0.035
WW |  | 29 |  | 434 | -0.933 | -0.9320529953917052 | -0.0009470046082949309
PREZISTA
US |  | 160 |  | 126 | 0.27 | 0.27 | 0
Intl |  | 164 |  | 140 | 0.171 | 0.2085670731707317 | -0.03756707317073171
WW |  | 324 |  | 266 | 0.218 | 0.2411616541353384 | -0.02316165413533834
OTHER INFECTIOUS DISEASES
US |  | 21 |  | 38 | -0.447 | -0.447 | 0
Intl |  | 301 |  | 124 | * | * | -0.03186710963455149
WW |  | 322 |  | 162 | 0.988 | * | -0.0297888198757764
 |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | FIRST QUARTER
 |  |  |  |  | % Change
 |  | 2012 |  | 2011 | Reported | Operational (1) | Currency
NEUROSCIENCE
US |  | 674 |  | 688 | -0.02034883720930233 | -0.02034883720930233 | 0
Intl |  | 973 |  | 1057 | -0.07947019867549669 | -0.05756764427625355 | -0.02090255439924314
WW |  | 1647 |  | 1745 | -0.05616045845272206 | -0.04349914040114614 | -0.01266131805157593
CONCERTA/METHYLPHENIDATE
US |  | 197 |  | 254 | -0.224 | -0.224 | 0
Intl |  | 111 |  | 108 | 0.028 | 0.058 | -0.03
WW |  | 308 |  | 362 | -0.149 | -0.14 | -0.009
INVEGA
US |  | 69 |  | 69 | 0 | 0 | 0
Intl |  | 52 |  | 51 | 0.02 | 0.03700000000000001 | -0.017
WW |  | 121 |  | 120 | 0.008 | 0.015 | -0.007
INVEGA SUSTENNA
US |  | 100 |  | 65 | 0.538 | 0.538 | 0
Intl |  | 61 |  | 0 | 1 | 1 | 0
WW |  | 161 |  | 65 | * | * | 0
RISPERDAL CONSTA
US |  | 113 |  | 114 | -0.009 | -0.009 | 0
Intl |  | 248 |  | 290 | -0.145 | -0.118 | -0.027
WW |  | 361 |  | 404 | -0.106 | -0.087 | -0.019
OTHER NEUROSCIENCE
US |  | 195 |  | 186 | 0.04838709677419355 | 0.04838709677419355 | 0
Intl |  | 501 |  | 608 | -0.1759868421052632 | -0.1622351973684211 | -0.01375164473684211
WW |  | 696 |  | 794 | -0.1234256926952141 | -0.1118954659949622 | -0.01053022670025189
ONCOLOGY
US |  | 107 |  | 64 | 0.672 | 0.672 | 0
Intl |  | 489 |  | 375 | 0.304 | 0.3372535787321063 | -0.03325357873210634
WW |  | 596 |  | 439 | 0.358 | 0.3852835570469799 | -0.02728355704697986
DOXIL/CAELYX
US |  | 7 |  | 64 | -0.891 | -0.891 | 0
Intl |  | 17 |  | 75 | -0.773 | -0.762 | -0.011
WW |  | 24 |  | 139 | -0.827 | -0.8211870503597122 | -0.005812949640287769
VELCADE
US |  | 0 |  | 0 | 0 | 0 | 0
Intl |  | 353 |  | 280 | 0.261 | 0.2929745042492918 | -0.03197450424929178
WW |  | 353 |  | 280 | 0.261 | 0.2929745042492918 | -0.03197450424929178
ZYTIGA
US |  | 100 |  | 0 | 100 | 100 | 0
Intl |  | 100 |  | 5 | * | * | -0.019
WW |  | 200 |  | 5 | * | * | -0.018615
OTHER ONCOLOGY
US |  | 0 |  | 0 | 0 | 0 | 0
Intl |  | 19 |  | 15 | 0.267 | 0.2965333333333334 | -0.02953333333333334
WW |  | 19 |  | 15 | 0.267 | 0.2965333333333334 | -0.02953333333333334
 |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | FIRST QUARTER
 |  |  |  |  | % Change
 |  | 2012 |  | 2011 | Reported | Operational (1) | Currency
TOTAL OTHER
US |  | 550 |  | 579 | -0.05 | -0.05 | 0
Intl |  | 690 |  | 785 | -0.121 | -0.100396178343949 | -0.02060382165605095
WW |  | 1240 |  | 1364 | -0.091 | -0.07914222873900292 | -0.01185777126099707
ACIPHEX/PARIET
US |  | 96 |  | 109 | -0.119 | -0.119 | 0
Intl |  | 126 |  | 130 | -0.031 | 0 | -0.031
WW |  | 222 |  | 239 | -0.071 | -0.05415899581589957 | -0.01684100418410042
PROCRIT/EPREX
US |  | 204 |  | 190 | 0.074 | 0.074 | 0
Intl |  | 172 |  | 207 | -0.169 | -0.14 | -0.029
WW |  | 376 |  | 397 | -0.053 | -0.03774055415617128 | -0.01525944584382872
OTHER
US |  | 250 |  | 280 | -0.1071428571428571 | -0.1071428571428571 | 0
Intl |  | 392 |  | 448 | -0.125 | -0.1114040178571429 | -0.01359598214285714
WW |  | 642 |  | 728 | -0.1181318681318681 | -0.1097651098901099 | -0.008366758241758242
TOTAL PHARMACEUTICAL
US |  | 3026 |  | 3391 | -0.1076378649365969 | -0.1076378649365969 | 0
Intl |  | 3107 |  | 2668 | 0.1645427286356822 | 0.1955427286356822 | -0.031
WW |  | 6133 |  | 6059 | 0.01221323650767453 | 0.02621323650767453 | -0.014
See footnotes at end of schedule
 |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 |  | FOURTH QUARTER |  |  |  |  |  | 0
 |  |  |  |  | Total
MAJOR NEW PHARM PRODUCTS (4) |  | 2011 |  | 2010 | % Change
(INCLUDED IN OTHER)
See footnotes at end of schedule
 |  |  |  |  |  | REPORTED SALES vs. PRIOR PERIOD ($[NAME])
 | FIRST QUARTER
 |  |  |  |  | % Change
 |  | 2012 |  | 2011 | Reported | Operational (1) | Currency
MEDICAL DEVICES AND DIAGNOSTICS   (2)(4)
CARDIOVASCULAR CARE
US |  | 176 |  | 242 | -0.273 | -0.273 | 0
Intl |  | 306 |  | 393 | -0.221 | -0.212 | -0.009
WW |  | 482 |  | 635 | -0.241 | -0.235 | -0.006
DIABETES CARE
US |  | 352 |  | 311 | 0.132 | 0.132 | 0
Intl |  | 318 |  | 326 | -0.025 | 0.001999999999999998 | -0.027
WW |  | 670 |  | 637 | 0.052 | 0.066 | -0.014
DIAGNOSTICS
US |  | 253 |  | 265 | -0.045 | -0.045 | 0
Intl |  | 259 |  | 256 | 0.012 | 0.025 | -0.013
WW |  | 512 |  | 521 | -0.017 | -0.011 | -0.006
GENERAL SURGERY
US |  | 593 |  | 596 | -0.005 | -0.005 | 0
Intl |  | 1032 |  | 1025 | 0.007 | 0.02577756097560975 | -0.01877756097560975
WW |  | 1625 |  | 1621 | 0.002 | 0.01387353485502776 | -0.01187353485502776
INFECTION PREVENTION/OTHER
US |  | 116 |  | 95 | 0.221 | 0.221 | 0
Intl |  | 128 |  | 121 | 0.058 | 0.065 | -0.007
WW |  | 244 |  | 216 | 0.13 | 0.134 | -0.004
ORTHOPAEDICS
US |  | 783 |  | 811 | -0.035 | -0.035 | 0
Intl |  | 710 |  | 692 | 0.026 | 0.04099999999999999 | -0.015
WW |  | 1493 |  | 1503 | -0.007 | 0 | -0.007
SPECIALTY SURGERY
US |  | 327 |  | 296 | 0.105 | 0.105 | 0
Intl |  | 301 |  | 281 | 0.071 | 0.093 | -0.022
WW |  | 628 |  | 577 | 0.088 | 0.09899999999999999 | -0.011
VISION CARE
US |  | 277 |  | 256 | 0.082 | 0.082 | 0
Intl |  | 480 |  | 466 | 0.03 | 0.026 | 0.004
WW |  | 757 |  | 722 | 0.048 | 0.045 | 0.003
TOTAL MEDICAL DEVICES AND DIAGNOSTICS
US |  | 2877 |  | 2872 | 0.001740947075208914 | 0.001740947075208914 | 0
Intl |  | 3534 |  | 3560 | -0.007303370786516854 | 0.006696629213483144 | -0.014
WW |  | 6411 |  | 6432 | -0.003264925373134328 | 0.004735074626865672 | -0.008
* Percentage greater than 100%
(1) Operational growth excludes the effect of currency
(2) Select areas (unaudited)
(3) Reported as U.S. sales
(4) Prior year amounts have been reclassified to conform to current year product disclosure